
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Dave Li explores the current information on the commercialization of advanced therapy medicinal products.
Published: September 17th 2019 | Updated:
Published: June 4th 2020 | Updated: